AcelRx Pharmaceuticals, Inc. (ACRX) Social Stream
ACELRX PHARMACEUTICALS INC (ACRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACRX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 26 months, ACRX's average price target has gone up $74.54.
ACRX reports an average of 10,015.01% for its upside potential over the past 33 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ACRX's average broker recommendation rating improved by 0 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACRX as an investment opportunity.
- ACRX has a greater number of analysts covering the stock than 34.77% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ACELRX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 654.62% of them.
- In the context of stocks in the small market cap category, ACELRX PHARMACEUTICALS INC's average analyst price target is greater than 239.32% of them.
- ACRX has a lower variance in analysts' estimates than -49.72% of Healthcare stocks.
Stocks similar to ACELRX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IBIO, AMPE, and VTGN.
View All Top Stocks by Price Target
Is ACRX a Buy, Hold or Sell? See the POWR Ratings now!